Is Semaglutide Safe?
Semaglutide has become one of the most talked-about weight loss medications in the country, and with that attention comes a lot of half-truths and misinformation. Some people describe it as life-changing, while others worry about side effects, long-term use, thyroid cancer warnings, or what happens if they stop taking it.
The honest answer is that semaglutide can be safe for the right patient when it’s prescribed correctly, monitored carefully, and used as part of a broader weight management plan. It’s still a medication, which means it has benefits, limits, and risks that need to be taken seriously.
When I talk with patients about semaglutide, I start with their medical history, current medications, weight loss goals, and overall health. I want to know if they have diabetes, chronic kidney disease, blood vessel disease, diabetic retinopathy, a personal or family history of thyroid tumors, or any history that could make using semaglutide less appropriate. Safety starts before the first semaglutide injection.
Semaglutide is a glucagon-like peptide 1 receptor agonist, often shortened to GLP-1. It helps regulate appetite, slow stomach emptying, and support better blood sugar control. For patients with type 2 diabetes, semaglutide can help lower blood sugar levels. For patients with obesity or excess weight, it can support chronic weight management when combined with diet and exercise.
FDA-approved semaglutide medications are used to treat obesity, assist with weight loss, and improve certain weight-related medical problems in appropriate patients, but semaglutide works best when patients understand its role. Semaglutide can help reduce appetite and make it easier to lose weight, but lasting weight loss still requires diet, movement, hydration, and lifestyle changes.
Most side effects from semaglutide are gastrointestinal. Patients may experience nausea, upset stomach, constipation, diarrhea, dry mouth, bloating, stomach pain, or reduced appetite, especially when starting the medication or increasing to a higher dose.
This is one reason I prefer gradual dosing. Many patients tolerate a semaglutide injection better when the dose increases slowly. If side effects become difficult, a lower dose or temporary pause may help, depending on the patient’s symptoms and treatment plan.
Patients should tell their provider if gastrointestinal issues become persistent, severe, or difficult to manage. We want you to get the best out of the medication while using it safely, which means not ignoring symptoms that may need medical attention.
Most patients using semaglutide don't experience serious side effects, but patients need to know what to watch for. Severe stomach pain, especially pain that does not improve or spreads toward the back, needs medical attention because it can be a warning sign of pancreatitis. Ongoing vomiting, dehydration, or worsening abdominal pain should also be reported.
An allergic reaction requires urgent care. Patients should seek emergency medical treatment if they develop difficulty breathing, trouble swallowing, swelling of the face or throat, severe rash, fast heartbeat, or feeling faint.
Low blood sugar can happen, especially when semaglutide is combined with insulin or other medicines that lower blood sugar. Symptoms may include sweating, shakiness, blurred vision, slurred speech, confusion, weakness, dizziness, or feeling faint. Patients with diabetes need careful monitoring because blood sugar levels may change as body weight, appetite, and medication needs change.
Semaglutide carries a warning related to thyroid tumors. It should not be used in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. This is why I ask about family history before prescribing semaglutide.
If there is a history of medullary thyroid cancer, thyroid tumors, or multiple endocrine neoplasia syndrome type 2, semaglutide may not be the right medication. Patients should also report a neck mass, hoarseness, trouble swallowing, or trouble breathing. These symptoms need evaluation.
Patients with any form of kidney disease need a careful safety discussion before taking semaglutide. The medication may not directly damage the kidneys in most patients, but dehydration from vomiting, diarrhea, or poor fluid intake can strain kidney function and may contribute to kidney problems or kidney failure in vulnerable patients.
This is especially important for patients with diabetes, high blood pressure, chronic kidney disease, or other medical conditions that affect the kidneys. If a patient develops severe nausea, vomiting, diarrhea, dizziness, or signs of dehydration, they should contact their healthcare professional promptly.
Because I am a surgeon, I pay close attention to semaglutide before surgery and other procedures. Semaglutide slows stomach emptying, which can matter during anesthesia. If food or fluid remains in the stomach longer than expected, there may be a higher risk of aspiration during sedation or general anesthesia.
Patients should always tell their plastic surgeon, primary care physician, anesthesiologist, and other healthcare providers if they are taking semaglutide. This includes any form of the medication, including the semaglutide injections, semaglutide tablets, compounded medication, or any GLP-1 medication used for weight loss or diabetes.
Timing may need to be adjusted before plastic surgery or other procedures. That decision should be made by the surgical and anesthesia team based on the patient’s health, dose, symptoms, and procedure type.
The semaglutide injection is usually taken as a once-weekly injection. Patients may inject it in their stomach area, thigh, or upper arm, depending on the medication instructions. Before each injection, patients should check the injection pen, confirm the expiration date, make sure the medication looks correct, remove the pen cap as directed, and use a new needle when required.
Used needles should be placed in an appropriate sharps container. Patients should never reuse needles or share an injection pen.
If you miss a dose, do not guess. The instructions can vary depending on the medication and how long it has been since the missed dose. In some cases, patients may take the missed dose on the same day or within a specific window. In other cases, they may need to wait until the next scheduled dose and return to the regular dosing schedule. Patients should follow the medication guide and call their provider if they are unsure.
Patients should be mindful if they drink alcohol while using semaglutide. Alcohol can affect blood sugar, increase nausea, worsen dehydration, and make healthy eating patterns harder to maintain. This is especially important for patients with diabetes or a history of gastrointestinal issues.
Semaglutide can support weight loss, but it's not a full weight loss solution by itself. Patients who get the best results are usually committed to lifestyle changes, including diet, protein intake, movement, sleep, and consistency. Losing weight too quickly can also contribute to fatigue, muscle loss, hair shedding, and nutritional issues, so a steady plan is safer and more sustainable.
So, is semaglutide safe? For the right patient, under the right supervision, it can be absolutely be a safe and effective tool for weight management and weight loss. It requires screening, proper dosing, honest communication, and a patient who understands that the medication works best alongside diet and exercise.
I don't want patients using semaglutide casually, guessing their dose, ignoring side effects, or hiding it from other healthcare providers before surgery. I want patients using semaglutide with structure, follow-up, and a clear plan. This is how we keep you safe and healthy while using semaglutide.
When used carefully, semaglutide can help patients lose weight, improve blood sugar control, reduce excess weight, and better control their health. The safest path starts with a consultation, a complete medical history, and a plan tailored to the patient’s body, goals, and long-term wellbeing.
Meet one on one with Dr. Zuriarrain in his Miami practice. Our team will listen to your goals, answer your questions, and help you choose the right next step.
Alexander Zuriarrain, MD, FACS is a Quadruple Board-Certified Plastic Surgeon who practices in Miami, Florida.
© 2026 Zuri Plastic Surgery. All Rights Reserved | Sitemap | Privacy Policy | Our Pet Policy | Terms & Conditions | HIPAA Privacy Notice | Accessibility
Join quadruple board-certified plastic surgeon Dr. Alexander Zuriarrain at his beautiful practice in Miami for a consultation. With more than 8,000 surgeries performed, Dr. Z has the skills and the experience to provide you with beautiful results.
Individual results will vary. No guarantee is stated or implied by any photo on this website. Testimonials on this site reflect individual, real life experiences of those who have used our products and/or services and are strictly the views of the reviewer.
Diplomate of the American Board of Plastic Surgery
Diplomate of the American Board of Surgery
Diplomate of the American Board of Cosmetic Surgery*
Diplomate of the American Board of Facial Cosmetic Surgery*
*The specialty recognition identified herein has been received from a private organization not affiliated with or recognized by the Florida Board of Medicine. The American Board of Cosmetic Surgery is a certifying board recognized by the American Board of Physician Specialties (ABPS), a nationally recognized medical specialty certifying organization requiring one year of cosmetic surgery training along with both a written and oral examination.
*If you would like to learn more about our privacy policies, please contact us at [email protected]
